Institution statistics

BAYER PHARMA AG - Germany

This institution has been merged with: BAYER.

Ranking results:

Past rankings:

2015
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2014
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000
2011
Criterium:	Position:
Overall Score:	> 1000
Networking Rank (Reputation):	> 1000

Ranking timeline:

European project participation (2010-01-01 - 2021-12-31 ):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 12
As coordinator: 0
As participant: 12
Sole participant: 0
Coordinator / Participant Ratio: 0^*

^*Ratio includes only projects with > 2 partners

Summary:

	Total project funding [€]:			Projects [No]:
Year:	coordinator^*	participant^*	per partner	as coordinator	as participant
2018	0	2.795.346	0		1
2017	0	32.200.000	0		2
2016	0	21.085.937	0		2
2015	0	6.463.625	498.433		2
2014	0	4.000.000	400.000		1
2013	0	3.935.721	95.400		1
2011	0	12.766.589	638.857		3

^*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:	Projects [No]:
MEDIZINISCHE UNIVERSITAET WIEN	5
GENOME RESEARCH	3
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE	3
JANSSEN PHARMACEUTICA NV	3
KATHOLIEKE UNIVERSITEIT LEUVEN	3
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD	3
ABBVIE INC	2
ACADEMISCH ZIEKENHUIS GRONINGEN	2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS	2
ASTELLAS PHARMA EUROPE BV	2
CANCER RESEARCH UK	2
CHARITE UNIVERSITAETSMEDIZIN BERLIN	2
ELI LILLY AND COMPANY LIMITED	2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM	2
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL	2
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR	2
KAROLINSKA INSTITUTE	2
LUNDS UNIVERSITET	2
MERCK SHARP & DOHME CORP	2
NOVARTIS PHARMA	2
NOVO NORDISK	2
PFIZER LIMITED	2
SANOFIAVENTIS DEUTSCHLAND	2
TAKEDA DEVELOPMENT CENTRE EUROPE	2
UNIVERSIDAD DE NAVARRA	2
UNIVERSITA DEGLI STUDI DI TORINO	2
UNIVERSITATSKLINIKUM ERLANGEN	2
UNIVERSITEIT MAASTRICHT	2
UNIVERSITY OF HELSINKI	2
UNIVERSITY OF LEEDS	2
UNIVERSITY OF NEWCASTLE UPON TYNE	2
UNIVERSITY OF TURKU	2
ABBVIE	1
ABBVIE DEUTSCHLAND GMBH & CO KG	1
ACTELION PHARMACEUTICALS	1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS	1
AMGEN	1
AMGEN LIMITED	1
ANTAROS MEDICAL AB	1
ASSOCIATION POUR LA RECHERCHE DE THERAPEUTIQUES INNOVANTES EN CANCEROLOGIE	1
ASTRAZENECA AB	1
AXCENTUA PHARMACEUTICALS AB	1
BARTS AND THE LONDON NHS TRUST	1
BIOXYDYN LIMITED	1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG	1
BRUKER BIOSPIN MRI	1
BUNDESINSTITUT FUR ARZNEIMITTEL UND MEDIZINPRODUKTE	1
CELGENE MANAGEMENT SARL	1
CHALMERS TEKNISKA HOEGSKOLA AB	1
CHRISTIANALBRECHTSUNIVERSITAET ZU KIEL	1
CHU HOPITAUX DE BORDEAUX	1
CONCENTRIS RESEARCH MANAGEMENT	1
CSL BEHRING	1
DANMARKS TEKNISKE UNIVERSITET	1
DSM MATERIALS SCIENCE CENTER BV	1
DSM R & D SOLUTIONS BV	1
ERASMUS UNIVERSITEIT ROTTERDAM	1
ERNSTMORITZARNDTUNIVERSITAET GREIFSWALD	1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL	1
EUROPEAN CANCER PATIENT COALITION	1
EUROPEAN GROUP FOR BLOOD AND MARROW TRANSPLANTATION	1
EUROPEAN HEMATOLOGY ASSOCIATION	1
EUROPEAN MOLECULAR BIOLOGY LABORATORY	1
EUROPEAN PATIENTS' FORUM	1
EUROPEAN RESEARCH INITIATIVE ON CLL EV	1
EUTOX WORKING GROUP OF THE ""EUROPEAN SOCIETY OF ARTIFICIAL ORGANS""	1
EXPERIMENTAL PHARMACOLOGY AND ONCOLOGY BERLINBUCH	1
F HOFFMANNLA ROCHE	1
FEDERAAL KENNISCENTRUM VOOR DE GEZONDHEIDSZORG	1
FONDAZIONE ITALIANA SINDROMI MIELODISPLASTICHE ETS	1
FRESENIUS MEDICAL CARE DEUTSCHLAND	1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS	1
FUNDACIO PRIVADA INSTITUT D'INVESTIGACIO ONCOLOGICA DE VALLHEBRON	1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III	1
FUNDACION HOSPITAL LA FE	1
FUNDACION INSTITUTO DE ESTUDIOS DE CIENCIAS DE LA SALUD DE CASTILLA Y LEON	1
GE HEALTHCARE LIMITED	1
GILUPI	1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT	1
GMV SOLUCIONES GLOBALES INTERNET SAU	1
GPOH GEMEINNUTZIGE	1
GROUP FOR RESEARCH ON ADULT ACUTE LYMPHOBLASTIC LEUKEMIA	1
GROUPE FRANCOPHONE DES MYELODYSPLASIES	1
HEINRICHHEINEUNIVERSITAET DUESSELDORF	1
HELMHOLTZZENTRUM FUER INFEKTIONSFORSCHUNG	1
HORIZON DISCOVERY LIMITED	1
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON	1
IKERLAN SCOOP	1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE	1
INSTITUT CURIE	1
INSTITUT FUER PHOTONISCHE TECHNOLOGIEN EV	1
INSTITUT GUSTAVE ROUSSY	1
INSTITUTO DE MEDICINA MOLECULAR	1
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ	1
INSTITUTO TUMORI ""GIOVANNI PAOLO II""	1
INTERNATIONAL ALLIANCE OF PATIENT'ORGANIZATIONS	1
INTERUNIVERSITAIR MICRO ELECTRONICA CENTRUM VZW	1
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI	1
ISTITUTO EUROPEO DI ONCOLOGIA	1
ITASUOMEN YLIOPISTO	1

Constancy:

Total number of partners:221

Partner loyalty:
Frequent Partner: (> 2 projects): 20
Rare Partner: 201

Frequent / Rare Partner Ratio: 0.1

Diversity:

Subjects:

Subject:	No:
HEALTH	2
MEDICINE, HEALTH	2
MEDICINE	2
MEDICAL BIOTECHNOLOGY	2
LIFE SCIENCES	2
INFORMATION	1
INFORMATION, MEDIA	1
SCIENTIFIC RESEARCH	1
MEDIA	1

Diversity index:0.43

Categories:

Category:	No:
BIOLOGICAL SCIENCES	4
RTD HORIZONTAL TOPICS	1
SOCIAL AND ECONOMIC CONCERNS	1

Project overview:

Start date	Project	acronym	role	funding	partners
2018-01-01	Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease	CaReSyAn	participant	2.795.346	16
2017-01-01	Imaging Biomarkers (IBs) for Safer Drugs: Validation of Translational Imaging Methods in Drug Safety Assessment - Sofia ref.: 116106	IB4SD-TRISTAN	participant	12.000.000	21
2017-01-01	Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026	HARMONY	participant	20.200.000	53
2016-10-01	Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966	PREFER	participant	6.000.000	33
2016-09-01	Biomarker Enterprise to Attack DKD - Sofia ref.: 115974	BEAt-DKD	participant	15.085.937	31
2015-10-01	European Network linking informatics and genomics of helper T cells	ENLIGHT-TEN	participant	3.354.685	11
2015-01-01	Improving Design, Evaluation and Analysis of early drug development Studies	IDEAS	participant	3.108.939	8
2014-01-01	A CANcer Development mOnitor	CanDo	participant	4.000.000	10
2013-01-01	RADical reduction of OXidative stress in cardiovascular diseases	RADOX	participant	3.935.721	9
2011-10-01	Ion Transport Proteins in Control of Cancer Cell Behaviour	IonTraC	participant	3.925.580	10
2011-02-01	Targeting the tumour microenvironment to improve pancreatic cancer prognosis	EPC-TM-Net	participant	3.000.000	17
2011-01-01	Predicting individual response and resistance to VEGFR/mTOR pathway therapeutic intervention using biomarkers discovered through tumour functional genomics	PREDICT	participant	5.841.009	14

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum